Venus Concept Inc. (VERO)
| Market Cap | 4.85M |
| Revenue (ttm) | 61.00M |
| Net Income (ttm) | -49.57M |
| Shares Out | 1.86M |
| EPS (ttm) | -71.58 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 22,291 |
| Open | 2.600 |
| Previous Close | 2.620 |
| Day's Range | 2.571 - 2.650 |
| 52-Week Range | 2.100 - 14.500 |
| Beta | 0.07 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 12, 2025 |
About VERO
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for d... [Read more]
Financial Performance
In 2024, Venus Concept's revenue was $64.83 million, a decrease of -15.09% compared to the previous year's $76.35 million. Losses were -$47.00 million, 26.2% more than in 2023.
Financial StatementsNews
Venus Concept Announces $6.5 Million Debt-to-Equity Exchange Transaction
Further reduction of outstanding debt by Madryn Asset Management improves the Company's balance sheet position Further reduction of outstanding debt by Madryn Asset Management improves the Company's b...
Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
$1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants $1.15 million upfront with up to an addi...
Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
$1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants $1.15 million upfront with up to an addi...
Venus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 Million
TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today it has entered into a def...
Venus Concept Inc. (VERO) Q1 2025 Earnings Call Transcript
Venus Concept Inc. (NASDAQ:VERO) Q1 2025 Earnings Conference Call May 15, 2025 8:00 AM ET Company Participants Rajiv De Silva - CEO Domenic Della Penna - CFO Conference Call Participants Thomas McGov...
Venus Concept Raises a Total of Approximately $2.7 Million in Gross Proceeds from Previously Announced Registered Direct Offerings of Common Stock
TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its previ...
Venus Concept Announces $1.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
TORONTO, April 11, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into...
Venus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its prev...
Venus Concept Announces $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into...
Venus Concept to Release First Quarter of Fiscal Year 2025 Financial Results on May 15, 2025
TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fi...
Venus Concept Announces $11 million Debt-to-Equity Exchange Transaction
Continued improvement of the Company's financial position through additional reduction of outstanding debt by Madryn Asset Management Continued improvement of the Company's financial position through ...
Venus Concept Inc. (VERO) Q4 2024 Earnings Conference Call Transcript
Venus Concept Inc. (NASDAQ:VERO) Q4 2024 Earnings Conference Call March 31, 2025 8:00 AM ET Company Participants Rajiv De Silva - CEO Domenic Della Penna - EVP and CFO Conference Call Participants Ma...
Venus Concept Announces Fourth Quarter and Fiscal Year 2024 Financial Results
TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the thre...
Venus Concept to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025
TORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and ...
Venus Concept Announces 1-for-11 Reverse Stock Split
TORONTO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it will effect a 1-f...
Venus Concept Announces Senior Management Changes
TORONTO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced several changes to its se...
Venus Concept Inc. (VERO) Q3 2024 Earnings Call Transcript
Venus Concept Inc. (NASDAQ:VERO) Q3 2024 Earnings Conference Call November 13, 2024 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Ope...
Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results
TORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three...
Venus Concept Announces Expansion of International Distribution Network and Certification of Products in India
Enhances future international growth profile with new partners and regulatory certifications in key global aesthetic markets Enhances future international growth profile with new partners and regulato...
Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024
TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fis...
Venus Concept Announces $15 million Debt-to-Equity Exchange Transaction
Second Substantial Reduction of Existing Debt by Madryn Asset Management in 2024; the Company has reduced its debt balance by 54% year-to-date Second Substantial Reduction of Existing Debt by Madryn A...
Venus Concept Announces Australian Regulatory Approval for Venus Bliss MAX
TORONTO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has clearance fr...
Venus Concept Inc. (VERO) Q2 2024 Earnings Call Transcript
Venus Concept Inc. (NASDAQ:VERO) Q2 2024 Earnings Conference Call August 13, 2024 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Opera...
Venus Concept Announces Second Quarter of Fiscal Year 2024 Financial Results
TORONTO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three...
Venus Concept Announces Regulatory Approval for Venus Bliss MAX in Canada
TORONTO, July 29, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a me...